May 2020: AGITG Trial Updates
SSGXXII approved by the Upper GI Working Party The SSGXXII trial concept was approved by the Upper GI Working... Read More
COVID-19 April update
As the COVID-19 pandemic continues to evolve, we are also continuing to evolve the way we work –... Read More
Welcoming Erin Burgess as Communications Manager
Erin recently joined the AGITG and GI Cancer Institute as Communications Manager. How did you come to work in... Read More
April 2020: AGITG Trial Updates
DYNAMIC-Pancreas DYNAMIC-Pancreas is one of three AGITG trials investigating ctDNA analysis, an emerging area in GI oncology that shows... Read More
March 2020: Colorectal cancer trial updates
Final patient joins MODULATE The final patient participating in the MODULATE clinical trial has now joined, meaning that all... Read More
COVID-19 member update
We want to reassure you that we are taking the COVID-19 situation very seriously. The health and safety... Read More
The 2020 AGITG Idea Generation Workshop
AGITG is hosting another Workshop in late 2020 in Sydney. Following the member survey for the 2020 research priorities,... Read More
February 2020: Trial Updates
Recent Sites Activated The following sites have opened for AGITG trials in the past month: Read More
Cancer Symptom Trials Annual Research Forum
This report was provided by Associate Professor Richard de Abreu Lourenco from the Centre for Health Economics Research... Read More
An update from ASCO GI
AGITG presentations Two AGITG trials were selected for presentation. The MONARCC trial was presented at the Trials in... Read More
AGITG Trial Updates December 2019
NEO-CREATE becomes the second AGITG Endorsed Study The pilot study NEO-CREATE has become the second AGITG... Read More
MODULATE reaches over 75% of its recruitment target
The MODULATE study, led by Prof Niall Tebbutt, is investigating the effectiveness, safety and tolerability of nivolumab with... Read More
Macquarie Bank colleagues invest in cancer research
Employees at Macquarie Bank were out in full force to support GI cancer research last Thursday night, raising... Read More
November 2019: Trial Updates
First site opens for MASTERPLAN The MASTERPLAN trial for pancreatic cancer patients has opened its first site at... Read More
GCCTI Workshop Report
Summary provided by Associate Professor Jeanne Tie. The Genomic Cancer Clinical Trials Initiative (GCCTI) works to support the... Read More
Dr Sharon Pattison awarded Research Fellowship
Dr Sharon Pattison has been awarded the 2019 New Zealand Society of Oncology Roche Translational Cancer Research Fellowship. Dr... Read More
Challenging the Enigmatic Nature of GI Cancers – ASM 2019
The 2019 Annual Scientific Meeting (ASM) of Australasian Gastro-Intestinal Trials Group (AGITG) convened by Dr Lorraine Chantrill, Medical... Read More
Member engagement in fundraising
The GI Cancer Institute is focussed on raising awareness of GI cancers and of AGITG research, and on... Read More
Announcing the 2019 AGITG Award Winners
The 2019 AGITG Annual Scientific Meeting was held from 21-23 August. At the meeting, seven awards were presented... Read More